AbbVie Reports First-Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
AbbVie (ABBV) Tops Q1 EPS by 2c, Revenue Misses, Offers FY Guidance
April 29, 2022 7:45 AM EDTAbbVie (NYSE: ABBV) reported Q1 EPS of $3.16, $0.02 better than the analyst estimate of $3.14. Revenue for the quarter came in at $13.54 billion versus the consensus estimate of $13.63 billion.
GUIDANCE:
AbbVie sees FY2022 EPS of $13.92-$14.12, versus the consensus of... More
